Loading...
Targeting RSV with Vaccines and Small Molecule Drugs
Respiratory syncytial virus (RSV) is the most significant cause of pediatric respiratory infections. Palivizumab (Synagis®), a humanized monoclonal antibody, has been used successfully for a number of years to prevent severe RSV disease in at-risk infants. However, despite intense efforts, there is...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3835183/ https://ncbi.nlm.nih.gov/pubmed/22335496 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|